Delivery Order SPE2DR25D1104-SPE2DR26FK831
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $2,406.07. This is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, issued under a non-competitive set-aside arrangement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $3,462.82. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package. This is a firm fixed-price delivery order with a ceiling value of $7,194.61 and an ultimate completion date of May 13, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $11,906.66. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract valued at $22,046.39, with completion scheduled for January 6, 2026. This non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $26,381.64. This firm fixed-price delivery order, issued on December 9, 2025, represents a non-competitive set-aside contract and is scheduled for completion by December 10, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,648.51 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract was executed on December 29, 2025, with an ultimate completion date of December 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $8,006.67. This is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and no set-aside designation was used. The contract represents a competitive award for pharmaceutical procurement supporting federal medical supply needs, with performance taking place at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed price contract valued at $9,799.56. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK831Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $11,562.78. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, utilizing no set-aside designation and awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving the federal medical supply chain. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen's capacity to fulfill this Jardiance order reflects its established role as a critical federal pharmaceutical vendor supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 1/4/26 |